1.
Open Forum Infect Dis
; 7(11): ofaa528, 2020 Nov.
Article
in English
| MEDLINE
| ID: mdl-33274249
ABSTRACT
Using a coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1-June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased.